---
$id: https://graph.org.ai/products/commodity/51141531
$type: Product
source: UNSPSC
code: "51141531"
title: "Valproic acid"
class: "51141500"
classTitle: "Anticonvulsants"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Valproic acid

**UNSPSC Code**: 51141531
**Class**: [Anticonvulsants](Anticonvulsants.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anticonvulsant agent with the molecular formula C8H16O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 614OI1Z5WI, chemically known as 4-pentanoic acid, 2-propyl-, (s)- but generally known as valproic acid, which bears US NIH Compound Identifier 3121. European Medicines Agency schedules Valproic acid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00015MIG. The term VALPROIC ACID is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 27, No. 10 1973, List 13). World Health Organization schedules valproic acid in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule valproic acid under HS 29159080 and SITC 51377. As of Q4 2014, VALPROIC ACID remains the US FDA Preferred Term for this commodity. Valproic acid bears US NLM identifiers UMLS ID C0042291 and NCI Concept Code C29536. SMILES: OC(=O)C(CCC)CCC.

